Security key
929033108
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 30,740,152
- Total 13F value
- $570,752,000
- Share change
- +33,445
- SEC-reported price per share
- $18.65
- Number of holders
- 49
- Value change
- -$868,415
- Number of buys
- 22
- Number of sells
- 24
- Shares outstanding
- 48,114,688
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2021
Institutions
49
Top holders
10
VOR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2021
Previous quarter: Q1 2021
Vor Biopharma Inc. SEC filings
Vor Biopharma Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 929033108
Recent filing periods:
Ownership snapshot
Top reported holders of VOR - VOR BIOPHARMA INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
31 Mar 2021
13F
Lead comparable stake: 23%
Showing 1-6 of 15 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 23%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership
Top 5
RA CAPITAL MANAGEMENT, L.P.
23%
5AM Venture Management, LLC
14%
FMR LLC
7.6%
Woodline Partners LP
2.4%
Johnson & Johnson Innovation - JJ...
2.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
23%
|
$479,314,000
11,120,973 shares
|
— | 31 Mar 2021 |
| 5AM Venture Management, LLC |
13F
Company
|
14%
|
$288,444,000
6,692,429 shares
|
— | 31 Mar 2021 |
| FMR LLC |
13F
Company
|
7.6%
|
$146,673,000
3,677,048 shares
|
— | 31 Mar 2021 |
| Woodline Partners LP |
13F
Company
|
2.4%
|
$49,706,000
1,153,267 shares
|
— | 31 Mar 2021 |
| Johnson & Johnson Innovation - JJDC, Inc. |
13F
Company
|
2.2%
|
$46,318,000
1,074,658 shares
|
— | 31 Mar 2021 |
| ORBIMED ADVISORS LLC |
13F
Company
|
1.7%
|
$35,917,000
833,333 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
49
Shares
30,740,152
Rows available
49
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
48
Q2 2021 holders
49
Holder diff
1
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q2 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend